AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Mar 7, 2016
5262_dirs_2016-03-07_e4428aa6-bcb9-4565-9213-7d00c4ec8a56.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3000R
GlaxoSmithKline PLC
07 March 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 7 March 2016 of the following increases in the notional allocation of GSK American Depositary Shares (ADSs) on 1 March 2016, at a price of $39.66 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:
| Director/PDMR | Number of ADSs |
| Dr M M Slaoui | 26 |
| Connected Person | Number of ADSs |
| Dr K Slaoui (Connected Person of Dr M M Slaoui) | 9 |
V A Whyte
Company Secretary
7 March 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEDLFBQXFFBBB